Lv1
10 积分 2024-11-12 加入
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
20小时前
已完结
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach
23小时前
已完结
The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention
5个月前
已完结
CDCP1: A promising diagnostic biomarker and therapeutic target for human cancer
5个月前
已完结
Receptor CDCP1 is a potential target for personalized imaging and treatment of poor outcome HER2+, triple negative and metastatic ER+/HER2- breast cancers
5个月前
已完结
Critical role of EphA3 in cancer and current state of EphA3 drug therapeutics
7个月前
已完结
Design and Rationale for a Phase II, Randomized, Open-Label, Two-Cohort Multicenter Interventional Study of Osimertinib with or Without Savolitinib in De Novo MET Aberrant, EGFR-Mutant Patients with Advanced Non-Small-Cell Lung Cancer: The FLOWERS Trial
8个月前
已完结
皖公网安备34019202002308
